chikungunya
viru
chikv
reemerg
mosquitoborn
alphaviru
recent
caus
larg
epidem
island
countri
around
indian
ocean
current
specif
drug
therapeut
treatment
use
prophylact
agent
infect
commerci
avail
vaccin
prohibitin
identifi
receptor
protein
use
chikungunya
viru
enter
mammalian
cell
recent
synthet
sulfonyl
amidin
flavaglin
fl
class
natur
occur
plant
compound
potent
anticanc
cytoprotect
neuroprotect
activ
shown
interact
directli
prohibitin
studi
therefor
sought
determin
whether
three
prohibitin
ligand
sulfonyl
amidin
flavaglin
abl
inhibit
chikv
infect
mammalian
cell
three
compound
inhibit
infect
reduc
viru
product
cell
treat
infect
ad
infect
pretreat
cell
minut
prior
infect
follow
wash
compound
result
signific
inhibit
entri
viru
product
result
suggest
investig
prohibitin
ligand
potenti
chikungunya
viru
entri
inhibitor
warrant
glycoprotein
kda
glycoprotein
mediat
fusion
viru
host
cell
membran
wherea
kda
glycoprotein
respons
receptor
bind
chikungunya
fever
first
formal
describ
outbreak
tanzania
viru
first
isol
outbreak
subsequ
shown
present
sever
part
africa
south
southeast
asia
outbreak
chikf
kenya
spread
indian
ocean
island
comoro
seychel
mauritiu
la
reunion
case
chikf
believ
occur
la
reunion
outbreak
subsequ
report
india
start
later
singapor
malaysia
thailand
part
southeast
asia
chikv
report
mani
countri
caus
particular
concern
case
autochthon
transmiss
european
countri
number
cell
type
includ
epitheli
endotheli
fibroblast
monocytederiv
macrophag
suscept
chikv
infect
wherea
monocyt
lymphocyt
nk
cell
monocytederiv
dendrit
cell
reportedli
suscept
chikv
infect
howev
one
studi
shown
chikv
infect
replic
monocyt
mechan
entri
viru
remain
somewhat
unclear
sourisseau
colleagu
propos
chikv
entri
hela
cell
via
clathrindepend
pathway
howev
bernard
colleagu
propos
entri
via
clathrinindepend
endocyt
pathway
studi
propos
cholesterol
ph
depend
step
requir
infect
recent
studi
identifi
receptor
protein
chikv
entri
mammalian
cell
homologu
pleiotrop
scaffold
protein
act
signal
hub
multipl
heterodim
organ
larg
ringlik
structur
diamet
nm
mitochondria
wherea
cytoplasm
endoplasm
reticulum
nucleu
plasma
membran
phb
form
heterodim
signal
protein
regul
mani
aspect
cell
physiolog
includ
mitochondri
biogenesi
surviv
metabol
cell
divis
cell
surfaceexpress
phb
shown
act
interact
molecul
vi
polysaccharid
salmonella
typhi
whereas
phb
express
surfac
insect
cell
shown
receptor
dengu
viru
interact
protein
one
major
insecticid
toxin
produc
bacillu
thuringiensi
current
specif
antivir
treatment
commerci
avail
vaccin
either
protect
treat
chikv
infect
although
number
vaccin
develop
program
flavaglin
famili
plant
natur
product
potent
anticanc
neuroand
cardioprotect
properti
studi
shown
prohibitin
directli
interact
target
class
molecul
synthet
sulfonyl
amidin
inhibit
bone
remodel
also
reportedli
bind
studi
therefor
sought
determin
whether
synthet
flavaglin
sulfonyl
amidin
abl
interfer
chikvprohibitin
interact
occur
receptor
bind
stage
chikv
infect
mammalian
cell
structur
flavaglin
c
figur
sulfonyl
amidin
synthes
accord
describ
procedur
puriti
compound
base
reversedphas
hplc
analys
hypersil
gold
column
mm
thermo
fisher
scientif
waltham
usa
follow
condit
flow
rate
mlmin
buffer
ch
cn
buffer
b
aqueou
trifluoroethano
acid
gradient
buffer
b
min
detect
l
nm
compound
initi
dissolv
dmso
stock
serial
dilut
dmem
work
solut
final
dmso
concentr
less
vehicledmem
use
control
consist
dmso
dilut
dmem
human
embryon
kidney
cell
line
atcc
cat
cultur
dmem
supplement
heatinactiv
fb
unitsml
penicillinstreptomycin
co
wherea
vero
atcc
cat
cultur
fb
unitsml
penicillinstreptomycin
chikv
use
studi
thai
isol
ecsa
strain
genotyp
ecsa
propag
stock
viru
produc
describ
previous
stock
titer
determin
standard
plaqu
assay
undertaken
essenti
describ
elsewher
immunofluoresc
perform
essenti
describ
previous
incub
cell
pfucel
chikv
hr
presenc
absenc
variou
compound
nm
cell
subsequ
fix
treatment
precool
paraformaldehyd
pb
min
incub
dilut
mous
monoclon
antialphaviru
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
usa
dilut
goat
polyclon
antibodi
santa
cruz
biotechnolog
follow
incub
dilut
alexa
fluor
label
donkey
antimous
igg
antibodi
invitrogen
thermo
fisher
scientif
waltham
usa
dilut
alexa
fluor
label
donkey
antigoat
igg
antibodi
invitrogen
thermo
fisher
scientif
cell
visual
olympu
fluoview
confoc
microscop
olympu
shinjukuku
tokyo
japan
equip
olympu
fluoview
softwar
v
imag
analysi
calcul
pearson
correl
coeffici
ci
carri
describ
previous
cell
viabil
determin
use
vybrant
mtt
cell
prolifer
assay
kit
invitrogen
thermo
fisher
scientif
accord
manufactur
recommend
percentag
cell
viabil
calcul
averag
eight
sampl
measur
compar
neg
control
vehicledmem
flow
cytometri
determin
cellular
infect
chikv
undertaken
exactli
describ
elsewher
cell
analyz
bd
facalibur
cytomet
becton
dickinson
bd
bioscienc
san
jose
ca
usa
data
analyz
use
cellquesttm
softwar
analysi
induct
apoptosi
respons
chikv
infect
perform
exactli
describ
elsewher
posit
control
cell
treat
dmso
dilut
complet
dmem
hr
experi
undertaken
independ
triplic
cell
seed
six
well
cultur
plate
grown
standard
condit
cell
reach
approxim
confluenc
cell
pre
incub
differ
concentr
sulfonyl
amidin
final
dilut
dmem
time
state
incub
equival
volum
vehicledmem
wash
incub
pfucel
chikv
ecsa
genotyp
absenc
drug
follow
infect
cell
wash
three
time
dmem
reincub
complet
medium
contain
compound
equival
vehicledmem
hr
cell
pellet
analyz
flow
cytometri
supernat
standard
plaqu
assay
determin
chikv
titer
experi
compound
ad
design
time
viru
infect
step
experi
undertaken
independ
triplic
duplic
plaqu
assay
cell
seed
six
well
cultur
plate
grown
standard
condit
cell
reach
approxim
confluenc
cell
pre
incub
differ
concentr
sulfonyl
amidin
final
dilut
dmem
incub
equival
volum
vehicledmem
minut
wash
twice
dmem
subsequ
incub
pfucel
chikv
ecsa
genotyp
absenc
drug
follow
infect
cell
wash
three
time
dmem
reincub
complet
medium
hr
cell
pellet
analyz
flow
cytometri
supernat
analyz
standard
plaqu
assay
determin
chikv
titer
experi
perform
independ
triplic
duplic
plaqu
assay
stock
chikv
ecsa
genotyp
incub
directli
differ
concentr
sulfonyl
amidin
indic
hr
titer
viru
directli
determin
standard
plaqu
assay
prepar
also
use
infect
cell
cultur
six
well
plate
reach
approxim
confluenc
viral
infect
viral
product
data
analyz
use
graphpad
prism
program
grappad
softwar
statist
analysi
signific
undertaken
pair
sampl
ttest
use
spss
spss
chicago
il
usa
p
consid
signific
cc
ic
valu
calcul
use
freewar
softwar
http
sciencegatewayorgprotocol
previou
studi
identifi
phb
chikv
receptor
protein
major
analysi
undertaken
human
microgli
cell
investig
effect
flavaglin
chikv
entri
studi
decid
use
cell
cell
suitabl
flow
cytometri
analysi
previou
studi
show
cell
express
phb
capabl
bind
chikv
therefor
initi
confirm
chikv
coloc
phb
surfac
cell
previous
shown
cell
shown
figur
found
cell
surfac
express
phb
distinct
coloc
phb
chikv
incub
cell
individu
variou
concentr
compound
investig
hr
assess
cell
viabil
use
mtt
assay
calcul
percentag
cell
viabil
averag
eight
replic
compar
neg
vehicl
dmem
posit
dmso
control
found
hr
incub
cell
viabil
sulfonyl
amidin
concentr
nm
less
nm
compar
neg
control
howev
saw
signific
cytotox
valu
nm
supplementari
fig
compound
show
approxim
equal
cc
valu
nm
nm
nm
sulfonyl
amidin
calcul
dose
respons
curv
see
supplementari
fig
confirm
result
mtt
assay
cultur
cell
incub
variou
concentr
sulfonyl
amidin
mock
incub
vehicledmem
hr
wash
cell
reincub
concentr
drug
hr
employ
twostep
incub
close
mimic
infect
protocol
undertaken
later
stage
found
approxim
apoptosi
induct
cell
treat
dmso
posit
control
howev
amount
apoptosi
cell
treat
differ
concentr
nm
compound
investig
compar
neg
control
mock
cell
treat
vehicl
dmem
supplementari
fig
evalu
potenti
virucid
activ
incub
stock
chikv
directli
compound
separ
differ
concentr
hr
vehicl
dmem
determin
viru
titer
standard
plaqu
assay
vero
cell
observ
direct
effect
compound
viru
supplementari
fig
repeat
experi
use
viruscompound
mixtur
infect
cell
found
signific
effect
abil
viru
infect
cell
moreov
plaqu
assay
analysi
highest
concentr
treatment
show
signific
effect
viru
product
supplementari
fig
combin
result
show
three
compound
test
possess
antichikv
virucid
activ
determin
effect
compound
chikv
infect
cultur
cell
preincub
without
sulfonyl
amidin
variou
concentr
hr
follow
infect
pfucel
chikv
mock
infect
serumfre
medium
without
compound
investig
hr
remov
extracellular
viru
wash
three
time
subsequ
incub
cell
complet
medium
standard
condit
presenc
compound
hr
harvest
cell
flow
cytometri
collect
supernat
standard
plaqu
assay
found
reduct
percentag
infect
cell
three
compound
concentr
nm
fig
c
e
wherea
addit
show
signific
reduct
percentag
cell
infect
chikv
nm
fig
similarli
observ
signific
reduct
viral
product
cell
incub
nm
three
compound
fig
f
supplementari
fig
wherea
addit
show
signific
effect
viru
product
nm
fig
supplementari
fig
maximum
effect
observ
nm
reduc
infect
viru
product
nearli
ic
compound
nm
determin
whether
compound
effect
entri
step
chikv
infect
incub
cell
highest
noncytotox
concentr
compound
nm
increasingli
shorter
time
preinfect
ad
infect
analyz
cell
supernat
hr
postinfect
previou
experi
found
sulfonyl
amidin
effect
number
infect
cell
amount
viru
product
cell
preincub
compound
fig
saw
effect
ad
two
compound
postinfect
fig
supplement
fig
show
effect
preincub
short
minut
preinfect
wherea
sulfonyl
amidin
show
effect
number
cell
infect
preincub
hr
preinfect
show
largest
effect
greatest
rang
time
point
effect
even
incub
hr
postinfect
signific
effect
number
cell
infect
amount
viru
produc
may
mean
continu
inhibit
viru
entri
complet
prevent
wash
step
suggest
may
remain
associ
phb
longer
time
either
sulfonyl
amidin
howev
addit
hr
postinfect
show
signific
effect
result
time
cours
experi
consist
action
compound
occur
attachmententri
step
chikv
infect
verifi
undertook
experi
short
minut
puls
pretreat
wash
compound
infect
cell
treatment
short
period
possibl
could
use
higher
concentr
compound
verifi
treat
cell
minut
differ
concentr
compound
nm
wash
cell
twice
dmem
incub
standard
condit
hr
assess
cell
viabil
undertaken
previous
found
evid
loss
cell
viabil
even
highest
concentr
use
nm
supplementari
fig
therefor
repeat
experi
infect
cell
wash
chikv
assay
degre
infect
viru
product
hr
postinfect
found
signific
reduct
infect
viru
product
condit
test
fig
supplementari
fig
viru
output
sulfonyl
amidin
reduc
nearli
puls
treatment
nm
compar
untreat
cell
final
confirm
compound
act
interf
receptor
bind
repeat
initi
coloc
experi
phb
chikv
time
presenc
absenc
compound
found
mark
reduct
coloc
chikv
phb
incub
viru
cell
presenc
compound
nm
compar
incub
compound
fig
prohibitin
locat
number
cell
compart
primarili
mitochondria
cell
surfac
express
also
demonstr
number
studi
phb
shown
interact
number
differ
pathogen
pathogen
protein
includ
chikv
dengu
sever
acut
respiratori
syndrom
coronaviru
hiv
footandmouth
diseas
viru
prohibitin
shown
specif
target
flavaglin
flavaglin
famili
natur
product
found
plant
genu
aglaia
famili
meliacea
mahogani
first
identifi
molecul
rocaglamid
rocaglamid
first
identifi
base
potent
antileukem
activ
sinc
natur
synthet
flavaglin
shown
potent
anticanc
properti
often
low
nanomolar
rang
recent
studi
suggest
flavaglin
includ
rocaglamid
silvestrol
promis
candid
treatment
leukemia
studi
shown
anticanc
fig
coloc
chikv
protein
phb
presenc
absenc
test
compound
cell
grown
glass
slide
incub
chikv
mock
incub
presenc
absenc
test
compound
nm
examin
cell
surfac
coloc
phb
red
chikv
protein
green
fluoresc
signal
observ
use
olympu
fluoview
confoc
microscop
scale
bar
magnif
shown
repres
noncontrast
adjust
unmerg
merg
imag
shown
action
flavaglin
deriv
least
part
specif
interact
phb
flavaglin
studi
undertaken
determin
whether
interact
flavaglin
phb
suffici
disrupt
interact
phb
chikv
result
consist
compound
act
entri
stage
possibl
physic
interf
bind
chikv
phb
receptor
maximum
inhibit
observ
approxim
viral
entri
seen
puls
treatment
cell
degre
inhibit
consist
seen
previou
antibodi
inhibit
experi
compound
test
show
littl
effect
ad
postentri
may
suggest
flavaglin
limit
potenti
util
prophylact
agent
natur
infect
synchron
administr
cours
diseas
could
therapeut
effect
prevent
new
cell
becom
infect
fact
antibodi
inhibit
experi
compound
test
show
maximum
effect
entri
may
indic
chikv
use
multipl
receptor
protein
enter
suscept
cell
compound
test
show
signific
cytotox
cell
condit
continu
cultur
consist
compound
known
anticanc
activ
howev
cytotox
observ
exposur
dramat
higher
dose
compound
administ
short
minut
puls
importantli
compound
show
toxic
normal
cell
display
evid
toxic
vivo
suggest
compound
inde
ligand
phb
could
form
basi
prophylact
therapeut
regim
chikv
outbreak
addit
support
inform
may
found
onlin
version
articl
publish
websit
figur
determin
cell
viabil
cell
incub
differ
concentr
dmso
b
c
sulfonyl
amidin
hour
determin
cell
viabil
use
mtt
assay
data
deriv
eight
replic
error
bar
show
sd
p
neg
vehicledmem
posit
dmso
figur
dose
respons
curv
gener
softwar
use
cc
calcul
figur
analysi
apoptosi
respons
treatment
flavaglin
cell
incub
differ
concentr
b
c
sulfonyl
amidin
hour
determin
amount
apoptosi
annexin
vpropidium
iodid
stain
analysi
flow
cytometri
experi
undertaken
independ
triplic
error
bar
show
sd
mock
vehicl
dmem
figur
analysi
virucid
activ
flavaglin
stock
chikv
incub
hr
presenc
absenc
variou
concentr
sulfonyl
amidin
viru
either
directli
assay
standard
plaqu
assay
b
use
infect
percentag
infect
determin
hour
flow
cytometri
c
viru
titer
supernat
nm
treatment
b
assay
standard
plaqu
assay
experi
undertaken
independ
triplic
duplic
plaqu
assay
error
bar
show
sd
mock
mock
viru
incub
vehicledmem
chikv
chikv
incub
vehicledmem
figur
viru
product
data
figur
plot
pfuml
figur
viru
product
data
figur
plot
pfuml
figur
determin
cell
viabil
puls
treatment
cell
incub
differ
concentr
b
c
sulfonyl
amidin
minut
cell
wash
incub
standard
condit
hr
determin
cell
viabil
use
mtt
assay
data
deriv
eight
replic
neg
vehicledmem
posit
dmso
control
run
parallel
error
bar
show
sd
p
figur
viru
product
data
figur
plot
pfuml
